Provectus Biopharmaceuticals, Inc. (PVCT)
Market Closed
30 Jul, 20:00
OTC PINK OTC PINK Primary 
XSTU $
0. 06
-0
-5.8064%
$
26.06M Market Cap
- P/E Ratio
- Div Yield
28,200 Volume
0 Eps
$ 0.06
Previous Close 
Want to track PVCT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Provectus Biopharmaceuticals, Inc. (PVCT) Statistics
Valuation metrics
Market Cap 26.06M
Enterprise value 28.6M
Trailing P/E (ttm) -4.66
Forward P/E -
PEG ratio 0.45
Price/Sales (ttm) 453.33
Price/Book (mrq) -3.87
Enterprise Value/Revenue 497.57
Enterprise Value/EBITDA -5.61
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 124.1K
Average volume (90 days) 132.93K
Price summary
52-Week low 0.04
52-Week high 0.1
Beta -
50-Day moving average 0.06
200-Day moving average 0.06
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:300
Last split Date 11 Apr 2002
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -97.75%
Operating margin -88.67%
Operational effectiveness
Return on assets -9.73%
Return on equity 0.9%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.01
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0
Total debt (mrq) -
Total Debt/Equity (mrq) -0.41
Current ratio (mrq) 0.06%
Book value per share (mrq) -0.02
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
